CD8A and neoplasm: However, our understanding of tumour hypoxia in HCC is still in its infancy, so we need to continue to delve deeper into the influence of hypoxia on the TME of HCC and on CD8+ T cells, and work to translate this into clinical applications to broaden new therapeutic strategies against HCC.